ÌÇÐÄÆƽâ°æ

GLP-1: Usage, Attitudes, and Consumer Impact Pulse Survey ÌÇÐÄÆƽâ°æ — June 2026

In June 2026, ÌÇÐÄÆƽâ°æ surveyed adults in three developed markets (the U.S., the UK, and Germany) on two dimensions of the GLP-1 story: how consumers are changing food and beverage purchasing, and what would drive current GLP-1 injector users to switch to a daily pill. With weight loss medication usage rising steadily, the results reveal a consumer landscape shifting more broadly and more pragmatically than the standard narrative suggests.

Log in or register to access full data.
Published by Matej Mikulic, Jul 1, 2026

Key insights

  • Global market share of Ozempic as of 2025
  • ****%

·¡»å¾±³Ù´Ç°ù’s Picks
·¡»å¾±³Ù´Ç°ù’s Picks
Current statistics on this topic

State of Health

Number of adults worldwide who were overweight or obese in 2020 and forecasts to 2035

State of Health

Obesity - prevalence in selected countries by gender 2024

State of Health

Percentage of obese U.S. adults by state 2024

Further recommended statistics

Further reports

Get the best reports to understand your industry

Overweight and obesity in the United States
Overweight and obesity in the United States
Physical activity
Physical activity
Diets and weight loss in the U.S.
Diets and weight loss in the U.S.
Food and Nutrition in the U.S. 2024
Food and Nutrition in the U.S. 2024
Overweight and obesity worldwide
Overweight and obesity worldwide
Obesity in Europe
Obesity in Europe
We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.

Get in touch